These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3015444)

  • 1. Second meeting of the WHO Collaborating Centres on AIDS: Memorandum from a WHO meeting.
    Bull World Health Organ; 1986; 64(1):37-46. PubMed ID: 3015444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired immunodeficiency syndrome: meeting of the WHO Collaborating Centres on AIDS.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Nov; 34(44):678-9. PubMed ID: 3932833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIDS and the WHO Collaborating Centres: memorandum from a WHO meeting.
    Bull World Health Organ; 1985; 63(6):1003-7. PubMed ID: 3879671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional recommendations to reduce sexual and drug abuse-related transmission of human T-lymphotropic virus type III/lymphadenopathy-associated virus.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Mar; 35(10):152-5. PubMed ID: 3005822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization of children infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus. Recommendations of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1987 Jan; 106(1):75-8. PubMed ID: 3024547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AIDS: the search for clues.
    WHO Chron; 1985; 39(6):207-11. PubMed ID: 3012884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 May; 35(20):334-9. PubMed ID: 3010072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Third meeting of the WHO Collaborating Centres on AIDS: memorandum from a WHO meeting.
    Bull World Health Organ; 1987; 65(5):601-6. PubMed ID: 3501341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired immune deficiency syndrome (AIDS)--recommendations of IMAP.
    International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
    IPPF Med Bull; 1986 Jun; 20(3):3-4. PubMed ID: 12268332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revision of the case definition of acquired immunodeficiency syndrome for national reporting--United States.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1985 Jun; 34(25):373-5. PubMed ID: 2989677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virologic studies of HTLV-III/LAV in pregnancy: case report of a woman with AIDS.
    Rogers MF; Ewing EP; Warfield D; Hardy AM; Emery DR; Wolf GC
    Obstet Gynecol; 1986 Sep; 68(3 Suppl):2S-6S. PubMed ID: 3016628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for preventing transmission of infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus during invasive procedures. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1986 Jun; 104(6):824-5. PubMed ID: 3010783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
    Yarchoan R; Redfield RR; Broder S
    J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T-lymphotropic virus type III/lymphadenopathy-associated virus antibody testing at alternate sites.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 May; 35(17):284-7. PubMed ID: 3010070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1986 Oct; 105(4):558-9. PubMed ID: 3019202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prospects for and pathways toward a vaccine for AIDS.
    Francis DP; Petricciani JC
    N Engl J Med; 1985 Dec; 313(25):1586-90. PubMed ID: 2999596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberculosis--United States, 1985--and the possible impact of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Feb; 35(5):74-6. PubMed ID: 3080659
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of screening as a preventive technology: the example of HTLV-III/LAV antibody testing.
    Ory HW; Koplan JP; Allen JR
    Isr J Med Sci; 1986; 22(7-8):524-8. PubMed ID: 3640749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [LAV type II: a second retrovirus associated with AIDS in West Africa].
    Clavel F; Brun-Vézinet F; Guétard D; Chamaret S; Laurent A; Rouzioux C; Rey M; Katlama C; Rey F; Champelinaud JL
    C R Acad Sci III; 1986; 302(13):485-8. PubMed ID: 3013382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AIDS: just the facts from specialists at Johns Hopkins.
    Finkbeiner A
    Johns Hopkins Mag; 1985 Dec; ():23-8. PubMed ID: 12314201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.